Dianthus Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $145.6M | $58.3M |
| FY2019 | — | $141.2M | $65.1M |
| FY2020 | — | $143.9M | $58.2M |
| FY2021 | — | $-17.2M | $131.7M |
| FY2022 | — | $-44.4M | $15.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $145.6M | $58.3M |
| FY2019 | — | $141.2M | $65.1M |
| FY2020 | — | $143.9M | $58.2M |
| FY2021 | — | $-17.2M | $131.7M |
| FY2022 | — | $-44.4M | $15.4M |